Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive
molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has been …

Background Patients with Ewing sarcoma or osteosarcoma have a median overall survival
of less than 12 months after diagnosis, and a standard treatment strategy has not yet been …

Background Based on preclinical data for the antitumour effect of zoledronate in osteosarcoma,
we assessed whether zoledronate combined with chemotherapy and surgery improved …

The SFOP-OS94 randomised multi-centre trial was designed to determine whether preoperative
chemotherapy regimen combining high-dose methotrexate courses and etoposide-…

Full article: CD163-positive tumor-associated macrophages and CD8-positive cytotoxic
lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma …

Background We report results from the phase I dose-finding and phase II expansion part of
a multicenter, open-label study of single-agent lenvatinib in pediatric and young adult …

Background In most countries, reference chemotherapy for osteosarcoma is MAP regimen (M
= high-dose methotrexate, AP = doxorubicin-cisplatinum). In France, the standard …

The identification of genes as markers for chromosome aberrations in specific tumors might
facilitate oncogenesis mechanism comprehension, cancer detection, prediction of clinical …

Pediatric patients with recurrent and refractory cancers are in most need for new treatments.
This study developed patient-derived-xenograft (PDX) models within the European …

Background High-risk medulloblastoma is defined by the presence of metastatic disease
and/or incomplete resection and/or unfavorable histopathology and/or tumors with MYC …